Author:
Santos C D,Tijeras-Raballand A,Serova M,Sebbagh S,Slimane K,Faivre S,de Gramont A,Raymond E
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Afonso FJ, Anido U, Fernandez-Calvo O, Vazquez-Estevez S, Leon L, Lazaro M, Ramos M, Anton-Aparicio L (2013) Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor. Clin Transl Oncol 15: 499.
2. Calvani N, Morelli F, Chiuri V, Gnoni A, Scavelli C, Fedele P, Orlando L, Maiello E, Lorusso V, Cinieri S (2013) Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike? Med Oncol 30: 578.
3. Chiatar SS, Eze OP, Schoenfeld AR (2013) Expression of VHL causes three-dimensional morphological changes in renal cells indicative of proximal tubule differentiation. Cell Dev Biol 2, e-pub ahead of print 12 August 2013; doi:10.4172/2168/9296.1000118.
4. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH (2000) Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 275: 25733–25741.
5. Cohen HT, McGovern FJ (2005) Renal-cell carcinoma. N Engl J Med 353: 2477–2490.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献